Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study

Cancer Causes and Control

Volumn 23, Issue 8, 2012, Pages 1349-1358

  Van Hemelrijck, Mieke ^a   Hermans, Ruben ^a   Michaelsson, Karl ^b   Melvin, Jennifer ^a,c   Garmo, Hans ^a,c   Hammar, Niklas ^d,e   Jungner, Ingmar ^d,f   Walldius, Göran ^d   Holmberg, Lars ^a,c  

^a GUY S HOSPITAL   (United Kingdom)

^b UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e ASTRAZENECA R AND D   (Sweden)

^f CALAB Research   (Sweden)

Author keywords

Albumin; Calcium; Prostate cancer

Indexed keywords

ALBUMIN; CALCIUM ION;

ADULT; AGE; ARTICLE; CALCIUM BLOOD LEVEL; CANCER GROWTH; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FATALITY; HAZARD RATIO; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK ASSESSMENT; SWEDEN;

ADULT; CALCIUM, DIETARY; COHORT STUDIES; DAIRY PRODUCTS; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; SERUM ALBUMIN; SWEDEN;

EID: 84864867844     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0015-x     Document Type: Article

References (29)

1. Chan JM, Giovannucci EL (2001) Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev 23(1):87-92
2. Butler LM, Wong AS, Koh WP, Wang R, Yuan JM, Yu MC (2010) Calcium intake increases risk of prostate cancer among Singapore Chinese. Cancer Res 70(12):4941-4948
3. Halthur C, Johansson AL, Almquist M, Malm J, Gronberg H, Manjer J et al (2009) Serum calcium and the risk of prostate cancer. Cancer Causes Control 20(7):1205-1214
4. Skinner HG, Schwartz GG (2008) Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 17(9): 2302-2305
5. Skinner HG, Schwartz GG (2009) The relation of serum parathyroid hormone and serum calcium to serum levels of prostatespecific antigen: a population-based study. Cancer Epidemiol Biomarkers Prev 18(11):2869-2873
6. Skinner HG, Schwartz GG (2009) A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 18(2):575-578
7. Schwartz GG (2009) Is serum calcium a biomarker of fatal prostate cancer? Future Oncol 5(5):577-580
8. Bringhurst F, Demay M, Krane S, Kronenberg H (2008) Bone and mineral metabolism in health and disease. In: Fauci A, Longo D, Kasper D, Braunwald E, Jameson J, Loscalzo J et al (eds) Harrrion's Prinicples of Internal Medicine. McGraw-Hill, New York
9. Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E (1998) Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem 44(8 Pt 1):1641-1649
10. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358(9298):2026-2033
11. Holme I, Aastveit AH, Jungner I, Walldius G (2008) Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 264(1):30-38
12. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009) Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 265(2):275-287
13. Walldius G, Jungner I, Kolar W, Holme I, Steiner E (1992) High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. Blood Press Suppl 4:35-42
14. Van Hemelrijck M, Garmo H, Binda E, Hayday A, Karagiannis SN, Hammar N et al (2010) Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study. Cancer Causes Control 9(21):1657-1667
15. Van Hemelrijck M, Garmo H, Holmberg L, Walldius G, Jungner I, Hammar, N Lambe M (2010) Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose. Cancer 117(10):2086-2095
16. Central Bureau for Statistics. Statistics Sweden. Stockholm, Sweden (2008); Available from: http://www.scb.se/
17. Akre O, Garmo H, Adolfsson J, Lambe M, Bratt O, Stattin P (2011) Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden. Eur Urol 60(3):554-563
18. Pintilie M (2006) Competing risks: a practical perspective. Willey, West Sussex
19. Grundmark B, Garmo H, Loda M, Busch C, Holmberg L, Zethelius B (2010) The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomarkers Prev 19(8):2088-2096
20. Pepe MS, Mori M (1993) Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12(8):737-751
21. Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE et al (2011) Endocrine regulation of male fertility by the skeleton. Cell 144(5):796-809
22. Hsing AW, Chokkalingam AP (2006) Prostate cancer epidemiology. Front Biosci 11:1388-1413
23. Huggins C, Hodges CV (1972) Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 22(4):232-240
24. Richter E, Srivastava S, Dobi A (2007) Androgen receptor and prostate cancer. Prostate Cancer Prostatic Dis 10(2):114-118
25. Berry PA, Birnie R, Droop AP, Maitland NJ, Collins AT (2011) The calcium sensor STIM1 is regulated by androgens in prostate stromal cells. Prostate 71(15):1646-1655
26. Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A et al (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 26(6):1948-1955
27. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ et al (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305(11):1119-1127
28. Holzmann M, Jungner I, Walldius G, Ivert I, Nordqvist T, Östergren J (2008) Apolipoproteins B and A-I, standard lipid measures and incidence of myocardial infarction in men and women, with or without chronic kidney disease. Study IV in Thesis for doctorial degree (PhD). In: Holzmann M (ed) Renal insufficiency, mortality and myocardial infarction. Karolinska Institutet, Stockholm
29. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040